Shawn Cline Tomasello - 06 Jun 2024 Form 4 Insider Report for Allovir, Inc. (KLRS)

Reporting relationship: Director
Issuer ticker: KLRS
Reported as of: 06 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jun 2024, 16:05:07 UTC
Prior SEC filing: 04 Jun 2024
Next SEC filing: 19 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Brett Hagen, as Attorney-in-Fact

Key filing fact

Shawn Cline Tomasello filed Form 4 for Allovir, Inc. (KLRS) on 07 Jun 2024.

Key facts

This page summarizes Shawn Cline Tomasello's Form 4 filing for Allovir, Inc. (KLRS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2024, 16:05.

Change

Previous filing in this sequence was filed on 04 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALVR transaction

Common Stock

Award

Transaction value: $0
Shares: +35,000
Change %: +100%
Price: $0.000000
Shares after: 70,000
Date: 06 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The shares shall vest upon the earlier to occur of (i) June 6, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.